Pressure Ulcer Prevention Innovation (PUPI) Boot.

Justin Magee (Designer), Mark Porter, Justin Quinn, Roisin McSwiggan (Other)

Research output: Non-textual formDesign

Abstract

This product system is revolutionary within pressure ulcer management, proposing a low-profile device suited for mobility. The work began as an Invest NI Innovation Voucher (iv1013087, £5.2K +VAT) where the design team used disruptive thinking to identify new directions for research development. A formal research collaboration between HSC Innovations and the University was established leading to contract research trough the NHSCT R&D discretionary fund (£6,290). Invention Disclosures were filed.  A systematic literature review and a patent search were conducted identifying the extent and prevalence of the issue and current treatment approaches. Three Service Improvement workshops within the NHSCT were observed using design artefacts. Within this PPI activity, Tissue viability experts informed the product design from initial sketch work through low-fidelity and high-fidelity prototype testing. Pressure ulcers have a profound negative effect on patient’s physical and psychological health, as well as social wellbeing and financial income. In 2020, the number of people over 75 years is expected to increase by 40% from that in 2009, with the number of people aged over 85 years expected to increase by 58%.“Older age” increases the rates of ill-health and disability dramatically. Disability affects those over 85 years at a rate of 67%, compared to 5% of young people and relates to pressure ulcer prevalence. The prevalence of heel pressure ulcer has been estimated at 14%, with some Intensive care units reporting a prevalence rate of 41%. Globally the incidence of pressure ulcers has been estimated from 1 to 56% in intensive care units. Pressure ulcers in the UK account for 4% of the annual budget totalling £1.4-2.1Million (Bennett et al 2004). The estimated cost (per person) of Cat. 1-4 pressure ulcers is reported to be between £1,214 and £14,108 (Dealey, C. et al 2012), with the most severe reaching £40,000 (Vaughan, P. et al 2013). There are 67,848 category 3 or 4 ulcers reported each year in the UK (PHA 2014). Litigation has impacted on the NHS, with some instances of pressure ulcers being termed as professional neglect as documented by the Department of Health (Stevenson et al 2013). The Department of Health has set targets to eliminate all avoidable pressure ulcers (Stevenson 2013). Magee is a 50% IP stakeholder.
LanguageUndefined
Publication statusPublished - 2016

Keywords

  • Pressure Ulcer
  • Pressure sore
  • Heel raise
  • Foot
  • Boot

Cite this

@misc{bf6e61a824374362942b66acc18c1b6a,
title = "Pressure Ulcer Prevention Innovation (PUPI) Boot.",
abstract = "This product system is revolutionary within pressure ulcer management, proposing a low-profile device suited for mobility. The work began as an Invest NI Innovation Voucher (iv1013087, £5.2K +VAT) where the design team used disruptive thinking to identify new directions for research development. A formal research collaboration between HSC Innovations and the University was established leading to contract research trough the NHSCT R&D discretionary fund (£6,290). Invention Disclosures were filed.  A systematic literature review and a patent search were conducted identifying the extent and prevalence of the issue and current treatment approaches. Three Service Improvement workshops within the NHSCT were observed using design artefacts. Within this PPI activity, Tissue viability experts informed the product design from initial sketch work through low-fidelity and high-fidelity prototype testing. Pressure ulcers have a profound negative effect on patient’s physical and psychological health, as well as social wellbeing and financial income. In 2020, the number of people over 75 years is expected to increase by 40{\%} from that in 2009, with the number of people aged over 85 years expected to increase by 58{\%}.“Older age” increases the rates of ill-health and disability dramatically. Disability affects those over 85 years at a rate of 67{\%}, compared to 5{\%} of young people and relates to pressure ulcer prevalence. The prevalence of heel pressure ulcer has been estimated at 14{\%}, with some Intensive care units reporting a prevalence rate of 41{\%}. Globally the incidence of pressure ulcers has been estimated from 1 to 56{\%} in intensive care units. Pressure ulcers in the UK account for 4{\%} of the annual budget totalling £1.4-2.1Million (Bennett et al 2004). The estimated cost (per person) of Cat. 1-4 pressure ulcers is reported to be between £1,214 and £14,108 (Dealey, C. et al 2012), with the most severe reaching £40,000 (Vaughan, P. et al 2013). There are 67,848 category 3 or 4 ulcers reported each year in the UK (PHA 2014). Litigation has impacted on the NHS, with some instances of pressure ulcers being termed as professional neglect as documented by the Department of Health (Stevenson et al 2013). The Department of Health has set targets to eliminate all avoidable pressure ulcers (Stevenson 2013). Magee is a 50{\%} IP stakeholder.",
keywords = "Pressure Ulcer, Pressure sore, Heel raise, Foot, Boot",
author = "Justin Magee and Mark Porter and Justin Quinn and Roisin McSwiggan",
year = "2016",
language = "Undefined",

}

TY - ADVS

T1 - Pressure Ulcer Prevention Innovation (PUPI) Boot.

AU - Porter, Mark

AU - Quinn, Justin

A2 - Magee, Justin

A2 - McSwiggan, Roisin

PY - 2016

Y1 - 2016

N2 - This product system is revolutionary within pressure ulcer management, proposing a low-profile device suited for mobility. The work began as an Invest NI Innovation Voucher (iv1013087, £5.2K +VAT) where the design team used disruptive thinking to identify new directions for research development. A formal research collaboration between HSC Innovations and the University was established leading to contract research trough the NHSCT R&D discretionary fund (£6,290). Invention Disclosures were filed.  A systematic literature review and a patent search were conducted identifying the extent and prevalence of the issue and current treatment approaches. Three Service Improvement workshops within the NHSCT were observed using design artefacts. Within this PPI activity, Tissue viability experts informed the product design from initial sketch work through low-fidelity and high-fidelity prototype testing. Pressure ulcers have a profound negative effect on patient’s physical and psychological health, as well as social wellbeing and financial income. In 2020, the number of people over 75 years is expected to increase by 40% from that in 2009, with the number of people aged over 85 years expected to increase by 58%.“Older age” increases the rates of ill-health and disability dramatically. Disability affects those over 85 years at a rate of 67%, compared to 5% of young people and relates to pressure ulcer prevalence. The prevalence of heel pressure ulcer has been estimated at 14%, with some Intensive care units reporting a prevalence rate of 41%. Globally the incidence of pressure ulcers has been estimated from 1 to 56% in intensive care units. Pressure ulcers in the UK account for 4% of the annual budget totalling £1.4-2.1Million (Bennett et al 2004). The estimated cost (per person) of Cat. 1-4 pressure ulcers is reported to be between £1,214 and £14,108 (Dealey, C. et al 2012), with the most severe reaching £40,000 (Vaughan, P. et al 2013). There are 67,848 category 3 or 4 ulcers reported each year in the UK (PHA 2014). Litigation has impacted on the NHS, with some instances of pressure ulcers being termed as professional neglect as documented by the Department of Health (Stevenson et al 2013). The Department of Health has set targets to eliminate all avoidable pressure ulcers (Stevenson 2013). Magee is a 50% IP stakeholder.

AB - This product system is revolutionary within pressure ulcer management, proposing a low-profile device suited for mobility. The work began as an Invest NI Innovation Voucher (iv1013087, £5.2K +VAT) where the design team used disruptive thinking to identify new directions for research development. A formal research collaboration between HSC Innovations and the University was established leading to contract research trough the NHSCT R&D discretionary fund (£6,290). Invention Disclosures were filed.  A systematic literature review and a patent search were conducted identifying the extent and prevalence of the issue and current treatment approaches. Three Service Improvement workshops within the NHSCT were observed using design artefacts. Within this PPI activity, Tissue viability experts informed the product design from initial sketch work through low-fidelity and high-fidelity prototype testing. Pressure ulcers have a profound negative effect on patient’s physical and psychological health, as well as social wellbeing and financial income. In 2020, the number of people over 75 years is expected to increase by 40% from that in 2009, with the number of people aged over 85 years expected to increase by 58%.“Older age” increases the rates of ill-health and disability dramatically. Disability affects those over 85 years at a rate of 67%, compared to 5% of young people and relates to pressure ulcer prevalence. The prevalence of heel pressure ulcer has been estimated at 14%, with some Intensive care units reporting a prevalence rate of 41%. Globally the incidence of pressure ulcers has been estimated from 1 to 56% in intensive care units. Pressure ulcers in the UK account for 4% of the annual budget totalling £1.4-2.1Million (Bennett et al 2004). The estimated cost (per person) of Cat. 1-4 pressure ulcers is reported to be between £1,214 and £14,108 (Dealey, C. et al 2012), with the most severe reaching £40,000 (Vaughan, P. et al 2013). There are 67,848 category 3 or 4 ulcers reported each year in the UK (PHA 2014). Litigation has impacted on the NHS, with some instances of pressure ulcers being termed as professional neglect as documented by the Department of Health (Stevenson et al 2013). The Department of Health has set targets to eliminate all avoidable pressure ulcers (Stevenson 2013). Magee is a 50% IP stakeholder.

KW - Pressure Ulcer

KW - Pressure sore

KW - Heel raise

KW - Foot

KW - Boot

M3 - Design

ER -